Add a reminder to your Google calendar so that you don't lose the event!
This event is held within the framework of the Grant of the Ministry of Science and Higher Education of the Russian Federation "Program for the creation and development of the "National Center for Personalized Medicine of Endocrine Diseases" (Agreement No. 075-15-2022-310 from 20.04.2022) for 2020-2025"
Организаторы:
15-28 August 2022
Conducted in an online format
Conference “Prospects for the use of gene therapy and biomedical cell product” with a summer school block for young scientists
Moscow Gene & Cell therapy perspectives сonference
Registration
*all abstracts will be assigned DOI
To submit your abstract, please use the form below. Each abstract will be reviewed by the conference program committee and, if accepted, will be included in the conference materials.
Participation in the conference is free.
Register as a listener and submit your abstract* to participate in the conference before July 15!
About the conference
Moscow Gene & Cell therapy perspectives conference is the first conference in Russia on the prospects of using genetic and cellular technologies. Within the framework of the conference, representatives of business, foundations, IT community, as well as scientists and doctors will exchange experiences and discuss the possibilities of developing and applying genetic research and technologies.
Sections
Oncological diseases
Diagnostics
Vaccines and immunity
Genetic hereditary diseases
Regulatory
Speakers
Genetic hereditary diseases

Sergey Popov, PhD

Head of the Department of Molecular Genetic Research of the NMIC of Endocrinology of the Ministry of Health of the Russian Federation

Circulating nucleic acids as potential biomarkers of human pathophysiological conditions

The main genetic mechanisms: DNA replication, repair and recombination and their biological role
Olga Glazova
Researcher at the Laboratory of Genome Editing of NMIC Endocrinology, Laboratory of Genomic Engineering of MIPT
Stem cells in ontogenesis. What we know about them and what remains to be found out

VDCN therapy as an example of the development of a gene therapy drug
Sofya Feoktistova 
Researcher at the Laboratory of Genetic Engineering at MIPT
Viral vectors (AB, AB, Lenti)
Navar Sakr
PhD student of the Laboratory of Genomic Engineering of MIPT, an employee of the Laboratory of Oncoendocrinology of the ENC
The CRISPR-Cas system: beyond genome editing

Clinical Development of Gene Therapies
Valaa Asaad
PhD student in the Laboratory of Genetic Engineering at MIPT
Screening and characterization of artificial variants of AAV for gene therapy
Almakdad Alsallum
PhD student in the Laboratory of Genetic Engineering at MIPT
Reprogramming somatic cells into pluripotent stem cells

Retina and retinal organoids: development and functional characteristics
Oncological diseases

Larisa Tsapkova, PhD

Senior Researcher at the Center for Personalized Medicine of the MSCC named after A.S. Loginov DZM

Analysis of gene expression in the differential diagnosis of follicular neoplasia of the thyroid gland
Anastasia Danishevich 
Geneticist of the Center for Personalized Medicine of the MSCC named after A.S. Loginov DZM
Results of the project on genome-wide sequencing of oncological patients in Moscow
Diagnostics

Sergey Popov, PhD

Head of the Department of Molecular Genetic Research of the NMIC of Endocrinology of the Ministry of Health of the Russian Federation

Commercial approaches to RNA sequencing of single cells.
Alexander Rusanov, PhD
 Leading Researcher at the Laboratory of Precision Biosystems of TSU
Skin cell models: application in biomedical and toxicological studies
Julia Krupinova
Endocrinologist, head of scientific projects of NCMU «National Center for Personalized Medicine of Endocrine Diseases»
Cellular atlas of the endocrine system.
Anton Pushkin
Researcher at the Laboratory of Molecular Oncology of the Federal State Budgetary Institution "NMIC Oncology" of the Ministry of Health of the Russian Federation
Spatial studies of gene expression.
Vaccines and immunity

Alexey Baldin, PhD

Member of the Laboratory of Oncoendocrinology of ENC, Laboratory of Genomic Engineering of MIPT

Models of central T-cell tolerance.

Tumor formation and tumor microenvironment.

Artificial immunorediting by changing the expression of genes in the thymus.

Feoktistova Sofya

Researcher at the Laboratory of Genetic Engineering at MIPT

Vector vaccines.
Afraa Mohammad
PhD student in the Laboratory of Genetic Engineering at MIPT
Human T-cell development from the embryo to the dish.

Development of an in vitro approach for obtaining early T-cell progenitors from human pluripotent stem cells.

Ksenia Trutneva, PhD

Researcher at the Laboratory of Molecular Endocrinology ENC

Antitumor vaccines.

The conference will be attended by representatives of